Baker Bros. Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-38,513,713
| Closed | -$653M | – | 139 |
|
|
2014
Q4 | $653M | Buy |
38,513,713
+17,539,036
| +84% | +$297M | 6.66% | 5 |
|
|
2014
Q3 | $250M | Buy |
20,974,677
+2,416,190
| +13% | +$28.8M | 3.15% | 10 |
|
|
2014
Q2 | $105M | Buy |
18,558,487
+12,768,348
| +221% | +$72M | 1.28% | 16 |
|
|
2014
Q1 | $21.3M | Buy |
5,790,139
+361,548
| +7% | +$1.33M | 0.27% | 38 |
|
|
2013
Q4 | $18.2M | Buy |
5,428,591
+1,000,000
| +23% | +$3.36M | 0.26% | 37 |
|
|
2013
Q3 | $18.7M | Buy |
4,428,591
+850,000
| +24% | +$3.6M | 0.27% | 33 |
|
|
2013
Q2 | $16.5M | Buy |
+3,578,591
| New | +$16.5M | 0.33% | 31 |
|